RY 156.04 -0.032% TD 79.81 -0.4615% SHOP 99.81 0.9303% CNR 158.79 0.6401% ENB 53.84 0.4478% CP 111.87 0.8019% BMO 112.71 0.7419% TRI 225.62 0.396% CNQ 50.46 2.4777% BN 67.8 1.194% ATD 76.93 -1.0674% CSU 4321.5298 0.3257% BNS 67.27 1.3102% CM 78.76 1.5603% SU 54.66 -1.1037% TRP 62.42 1.2162% NGT 70.54 0.2558% WCN 251.32 0.3153% MFC 36.65 -0.0818% BCE 47.21 0.3187%
Last update at 2024-08-30T19:45:00Z
Breakdown |
---|
Breakdown |
---|
Breakdown |
---|
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
DHB Delivra Health Brands Inc. |
- -% | 0.03 | - | - | 0.80 | 2.56 | 0.72 | 3.80 |
RX Biosyent Inc. |
0.05 0.46% | 10.85 | 16.47 | 16.26 | 3.21 | 2.88 | 2.32 | 8.03 |
LOVE Cannara Biotech Inc |
-0.04 5.56% | 0.68 | 10.00 | - | 1.26 | 0.90 | 1.98 | 7.20 |
DB Decibel Cannabis Company Inc |
- -% | 0.07 | - | 3.38 | 0.48 | 1.17 | 0.87 | 39.48 |
LSL LSL Pharma Group Inc. |
-0.005 1.01% | 0.49 | - | - | 4.65 | 4.23 | 6.13 | -14.2493 |
Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. The company is involved in selling of cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It offers its products under LivRelief, Dream Water, and LivRelief infused brand names. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.
999 Canada Place, Vancouver, BC, Canada, V6C 3E2
Name | Title | Year Born |
---|---|---|
Mr. Frank A. Holler MBA | Independent Exec. Chairman | 1957 |
Mr. Gord Davey | Pres, CEO & Director | NA |
Mr. Jack Z. Tasse C.M.A., CPA | CFO & Corp. Sec. | NA |
Mr. Matthew Wagar | Sr. VP of Marketing & Innovation | NA |
Ms. Ann Gallery | Sr. VP of Corp. Communications | NA |
Mr. Will Stewart | Sr. VP of Corp. & Public Affairs | 1976 |
Mr. Christopher Podolsky CA, CPA | Advisor | NA |
Mr. Jonathan David Hartshorn | Pres & CEO of Satipharm | 1970 |
Mr. Kwong Choo CGA, CPA | VP of Fin. | 1964 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.